Meticorten and Xarelto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meticorten (prednisone) and Xarelto (rivaroxaban). Common drug interactions include thrombosis among females and gastritis erosive among males.

The phase IV clinical study analyzes what interactions people have when they take Meticorten and Xarelto. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Meticorten?

Meticorten has active ingredients of prednisone. eHealthMe is studying from 1,708 Meticorten users. Check the latest studies of Meticorten.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,377 Xarelto users. Check the latest studies of Xarelto.

On Jul, 26, 2026

16 people who take Meticorten and Xarelto together, and have interactions are studied.

Meticorten and Xarelto drug interactions.

What are the common drug interactions of Meticorten and Xarelto, by gender? *:

female:

Thrombosis (formation of a blood clot inside a blood vessel)
Erysipelas (bacterial skin infection)
Abdominal hernia
Dysphagia (a condition in which swallowing is difficult or painful)
Nausea (feeling of having an urge to vomit)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Abdominal distension

male:

Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Mobility decreased (ability to move is reduced)
Skin discolouration (change of skin colour)
Ageusia (loss of taste functions of the tongue)
Aggression
Decreased appetite
Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
Diverticulitis intestinal haemorrhagic (digestive disease which involves the formation of pouches (diverticula) within the intestinal wall with bleeding)
Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Meticorten and Xarelto, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood disorder
Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

n/a

60+:

Thrombosis (formation of a blood clot inside a blood vessel)
Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
Craniocerebral injury (injury to cranium and brain)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Dizziness
Epistaxis (bleed from the nose)
Haemorrhagic transformation stroke (haemorrhages develop inside areas of ischemia)
Mobility decreased (ability to move is reduced)
Skin discolouration (change of skin colour)
Ageusia (loss of taste functions of the tongue)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 50.00%
High Blood Cholesterol: 4 people, 25.00%
Gastric Disorder (disease of stomach): 4 people, 25.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 18.75%
Arthropathy: 3 people, 18.75%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 18.75%
High Blood Pressure: 2 people, 12.50%
Embolism Venous (embolus may pass into the arterial system): 2 people, 12.50%
Diabetes: 2 people, 12.50%
Depression: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Meticorten and Xarelto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously